Advertisement

Ulcus-Therapie pp 225-253 | Cite as

Cimetidin

  • E. Hentschel
Conference paper
Part of the Interdisziplinäre Gastroenterologie book series (GASTROENTEROLOG)

Zusammenfassung

Receptoren sind als hypothetische Orte an der Zelloberfläche aufzufassen, deren Verbindung mit einem Agonisten (physiologischer Wirkstoff oder Pharmakon) von einer spezifischen Leistung der Zelle gefolgt ist. Antagonisten besitzen ebenfalls eine Affinität zum Receptor, können aber die spezifische Wirkung in der Zelle nicht hervorrufen. Sie konkurrieren mit den Agonisten um die Bindung am Receptor und können diese, wenn sie in höherer Konzentration vorhanden sind, vom Receptor verdrängen (kompetitive und dosisabhängige Hemmung).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Aadland, E., Berstad, A.: Parietal and chief cell sensitivity to pentagastrin Stimulation before and after Cimetidine treatment for duodenal ulcer. Scand. J. Gastroenterol. 14, 111–114(1979)PubMedCrossRefGoogle Scholar
  2. 2.
    Aadland, E., Berstad, A., Semb, L.S.: Inhibition of pentagastrin-stimulated gastric secretion by Cimetidine in healthy subjects. In: Proc. 2nd International Symposium Histamine H2-Receptor Antagonists. Burland, W.L., Simkins, M.A. (eds.), pp. 87–97. Amsterdam: Excerpta Medica 1977Google Scholar
  3. 3.
    Ackermann, D.: Über den bacteriellen Abbau des Histidins. Hoppe-Seylers Z. Physiol. Chem. 65, 504–510 (1910)CrossRefGoogle Scholar
  4. 4.
    Arnold, R., Koop, H., Nesslinger, A., Creutzfeldt, W.: Einfluß einer Cimetidin-Langzeittherapie auf das basale und nahrungsstimulierte Serumgastrin, die antrale Gastrinkonzentration und die antrale G-Zelldichte. Z. Gastroenterol. 17, 570–571 (1979)Google Scholar
  5. 5.
    Ash, A.S.F., Schild, H.O.: Receptors mediating some actions of histamine. Br. J. Pharmacol. Chemother, 27, 427–439 (1966)PubMedGoogle Scholar
  6. 6.
    Avella, J., Madsen, J.E., Binder, H.J., Askenase. P.W.: Effect of histamine-H2-recep- tor antagonists on delayed hypersensitivity. Lancet 1978 I, 624Google Scholar
  7. 7.
    Bank, S., Barbezat, G.O., Novis, B.H., et al.: Histamine H2-receptor antagonists in the treatment of duodenal ulcers. S. Afr. Med. J. 50, 1781–1785 (1976)PubMedGoogle Scholar
  8. 8.
    Bank, S., Barbezat, G.O., Vinik, A.I., Halter, F., Helman, C.A.: Cimetidine and serum gastrin levels in man. In: Proc. 2nd Int. Symp. Histamine H2-Receptor Antagonists. Burland, W.L., Simkins, M.A. (eds.), pp. 155–162. Amsterdam: Excerpta Medica 1977Google Scholar
  9. 9.
    Barbezat, G.O., Bank, S.: Basal acid output response to Cimetidine in man. In: Proc. 2nd International Symposium Histamine H2-Receptor Antagonists. Burland, W.L., Simkins, M.A. (eds.), pp. 110–119. Amsterdam: Excerpta Medica 1977Google Scholar
  10. 10.
    Barbezat, G.O., Bank, S.: Effect of prelonged Cimetidine therapy on gastric acid secretion in man. Gut 19 151–154 (1978)PubMedCrossRefGoogle Scholar
  11. 11.
    Bardhan, K.D.: Intermittent treatment of duodenal ulcer with Cimetidine. Br. Med. J. 1980 II, 20–22Google Scholar
  12. 11a.
    Bardhan, K.D., et al.: Longterm treatment with Cimetidine in duodenal ulceration. Lancet 19771, 900Google Scholar
  13. 12.
    Bardhan, K.D., Saul, D.M., Balmforth, G.V., et al.: The effect of Cimetidine on duodenal ulceration. Gut, 20, 68–74 (1979)CrossRefGoogle Scholar
  14. 13.
    Bateson, M.C., Browning, M.C.K., Maconnachie, A.: Galactorrhea with cimetidine. Lancet 1977 II, 247–248Google Scholar
  15. 14.
    Bauer, H., Schmidt, G.F.: Tierexperimentelle und klinische Untersuchungen zur Kombination von Cimetidin und Somatostatin. Z. Gastroenterol. 18, 314–319 (1980)PubMedGoogle Scholar
  16. 15.
    Bénichoux, R., Martin, F.: Perforation gastroduodenale au cours d’un traitement par la Cimetidine. Nouv. Presse Med. 7, 116 (1978)Google Scholar
  17. 16.
    Berstad, A., Aadland, E., Carlsen, E., Myren, J., Semb, L.S., Kruse-Jensen, A.: Maintenance treatment of duodenal ulcer patients with a single bedtime dose of Cimetidine. Scand. J. Gastroenterol. 14, 827–831 (1979)PubMedCrossRefGoogle Scholar
  18. 17.
    Berstad, A., Aadland, E., Bjerke, K., Carlsen, E.: Relapse of duodenal ulcer following treatment with Cimetidine or trimipramine (abstract). XI Int. Congress of Gastroent., Acta Hepatogastroenterol. (Stuttg.) 257 (1980)Google Scholar
  19. 18.
    Bianchi Porro, G., Petrillo, M.: A controlled trial comparing Cimetidine with carbenoxolon sodium in gastric ulcer (short- and long-term study). Drugs Exp. Clin. Res. 5, 173–176 (1979)Google Scholar
  20. 19.
    Bianchi Porro, G., Cheli, R., Dobrilla, G., et al.: Treatment of active duodenal ulcer with oral Cimetidine: A multicenter controlled endoscopic trial. Digestion 17, 383–386 (1978)CrossRefGoogle Scholar
  21. 20.
    Binder, H.J., Donaldson, R.M.: Effect of Cimetidine on intrinsic factor and pepsin secretion in man. Gastroenterology 74, 371–375 (1978)PubMedGoogle Scholar
  22. 21.
    Binder, H.J., Cocco, A., Crossley, R.J., et al.: Cimetidine in the treatment of duodenal ulcer. A multicentre double blind trial. Gastroenterology 74, 380–388 (1978)PubMedGoogle Scholar
  23. 22.
    Black, J.W., Duncan, W.A.M., Durant, C.J., Gavellin, C.R., Parsons, M.E.: Definition and antagonism of histamine H2-receptors. Nature 236, 385–390 (1972)PubMedCrossRefGoogle Scholar
  24. 23.
    Blackwood, W.S., Maudgal, D.P., Pickard, R.G., Lawrence, D., Northfield, T.C.: Cimetidine in duodenal ulcer. Lancet 1976 II, 174–176Google Scholar
  25. 24.
    Blum, A.L., Siewert, J.-R., Halter, F.: Ulkustherapie mit Cimetidin. Dtsch. Med. Wochenschr. 193, 135–139 (1978)CrossRefGoogle Scholar
  26. 25.
    Bodemar, G., Walan, A.: Cimetidine in the treatment of active duodenal and prepyloric ulcers. Lancet 1976 II, 161–164Google Scholar
  27. 26.
    Bodemar, G., Walan, A.: Maintenance treatment of recurrent peptic ulcer by cimetidine. Lancet 1978 I, 403–407Google Scholar
  28. 27.
    Bodemar, G., Walan, A.: Two-year follow-up after one year treatment with cimetidine or placebo. Lancet 1980 I, 38–39Google Scholar
  29. 28.
    Bohman, T., Myren, J., Flaten, O.: The effect of the new H2-receptor antagonist ranitidine, on the histamine-stimulated gastric secretion. Acta Hepatogastroenterol. (Stuttg.) 27, 73 (1980)Google Scholar
  30. 29.
    Bonfils, S., Mignon, M., Kloeti, G., Jian, M.: Therapeutic assessment of histamine H2- blockers in 10 cases of Zollinger-Ellison syndrome. Gastroenterology 72, A 3 /813 (1977)Google Scholar
  31. 30.
    Bournerias, F., Ganeval, D., Danan, G.: Trouble du rythme cardiaque mortel au cours d’un traitement par la cimetidine. Nouv. Presse Méd. 7, 2069 (1978)PubMedGoogle Scholar
  32. 31.
    Brimblecombe, R.W., Duncan, W.A.M., Durant, G.J., Emmett, J.C., Ganellin, C.R., Parsons, M.E.: Cimetidine-a non-thiourea H2-receptor antagonist. J. Int. Med. Res. 3, 86–92 (1975)Google Scholar
  33. 32.
    Burland, W.: Evidence for the safety of Cimetidine in the treatment of peptic ulcer disease. In: International Symposium Histamine H2-Receptor Antagonists. Creutzfeldt, W. (ed.), pp. 261–281. Amsterdam: Excerpta Medica 1978.Google Scholar
  34. 33.
    Burland, W.L., Hawkins, B.W., Beresford, J.: Cimetidine for the prevention of recurrence of duodenal ulcer: An international collaborative study. Postgrad. Med. J. 56 73–176 (1980)CrossRefGoogle Scholar
  35. 34.
    Carlson, H.E., Ippoliti, A.F.: Cimetidine, an H2-histamine, stimulates prolactin secretion in man. J. Clin. Endocrinol. Metab. 45, 367–369 (1977)PubMedCrossRefGoogle Scholar
  36. 35.
    Carstensen, H.E., Bülow, S., Hart Hansen, O., et al.: Cimetidine for severe gastroduodenal hemorrhage: A randomised controlled trial. Scand. J. Gastroenterol. 15 103–105 (1980)PubMedCrossRefGoogle Scholar
  37. 36.
    Carter, D.C., Forrest, J.A.H., Logan, R.A., Ansell, J., Lidgard, G., Heading, R.C., Sherman, D.J.C.: Effect of histamine H2-receptor antagonist, Cimetidine, on gastric secretion and serum gastrin during insulin infusion in man. Scand. J. Gastroenterol. 11, 565–570 (1976)PubMedGoogle Scholar
  38. 37.
    Celestin, L.R., Spence, R.W.: Perforation of chronic peptic ulcer after Cimetidine. Br. Med. J. 1977 II 1149Google Scholar
  39. 38.
    Celestin, L.R., Harvey, V., Saunders, J.H.B., et al.: Treatment of duodenal ulcer by metiamide. Lancet 1975 II, 779–781Google Scholar
  40. 39.
    Ciclitira, P.J., Machell, R.J., Farthing, M.J., Dick, A.P., Hunter, J.O.: Experience with Cimetidine in the treatment of gastric ulceration. Gut 18, A419–A420 (1977)Google Scholar
  41. 40.
    Cohen, J., Weetman, A.P., Dargie, H.J., Krikler, D.M.: Lifethreatening arrhythmias and intravenous Cimetidine. Br. Med. J. 1979 II, 768Google Scholar
  42. 41.
    Cole, J. J., Charles, B.G., Ravenscroft, P.J.: Interaction of Cimetidine with tetracycline absorption. Lancet 1980 II, 536Google Scholar
  43. 42.
    Colin-Jones, D.: Comparative trials of Cimetidine for gastric ulcer. In: International Symposium on Histamine H2-Receptor Antagonists. Creutzfeldt, W. (eds.), pp. 244–248. Amsterdam: Excerpta Medica 1978Google Scholar
  44. 43.
    Commens, C.A., Graves, M.W.: Cimetidine in chronic idiopathic urticaria: A randomised double blind study. Br. J. Dermatol. 99, 675–679 (1978)PubMedCrossRefGoogle Scholar
  45. 44.
    Corbett, C.L., Holdsworth, C.D.: Fever, abdominal pain, and leucopenia during treatment with Cimetidine. Br. Med. J. 1978 I, 753–754Google Scholar
  46. 45.
    Craven, E.R., Whittington, J.M.: Agranulocytosis four months after Cimetidine therapy. Lancet 1977 II, 294–295Google Scholar
  47. 46.
    Crean, G.P., Daniel, D., Leslie, G.B., Bates, C.: The effects of prolonged administration of large doses of Cimetidine on the gastric mucosa of rats. In: Cimetidine–Westminster Hosp. Symp. Wastell, C., Lance, P. (eds.), pp. 191–206. Edinburgh: Churchill Livingstone 1978Google Scholar
  48. 47.
    Cremer, M., Toussaint, J., Derumier, J., Deltenre, M.: Etude en double aveugle de l’effet de la Cimetidine dans l’ulcère duodénal et dans l’ulcère gastrique. In: Proceedings of the National Symposium on Cimetidine, pp. 30–39. Brussels, Excerpta Medica (1977)Google Scholar
  49. 48.
    Curtes, J.P., Develay, P.: Intoxication aiguë par absorption volontaire d’un antagoniste des récepteurs histaminiques: la Cimetidine. Bull. Med. Leg. Toxicol. Med. 20, 137–139 (1977)Google Scholar
  50. 49.
    Dale, H.H., Laidlaw, P.P.: The physiological actions of beta-imidazolylethylamine. J. Physiol. (Lond.) 41, 318–344 (1910)Google Scholar
  51. 50.
    Daubresse, J.C., Meunier, J.C., Ligny, G.: Plasma-prolactin and Cimetidine. Lancet 1978 I, 99Google Scholar
  52. 51.
    Delaunois, L.: Hypersensitivity to Cimetidine. N. Engl. J. Med. 1979 I, 1216Google Scholar
  53. 52.
    Delle Fave, G.F., Tamburrano, G., De Magistris, L., Natoli, C., Santoro, M.L., Carratu, R., Torsoli, A.: Variations in serum prolactin following Cimetidine treatment for peptic ulcer disease. Rend. Gastroenterol. 9, 142–143 (1977)Google Scholar
  54. 53.
    Dobrilla, G.: Placebo controlled studies with ranitidine in the treatment of duodenal ulcer. In: Europ. Congr. of gastrointest. Endoscopy, Hamburg, 1980. Drug symposium on ranitidine.Google Scholar
  55. 54.
    Dobrilla, G., Valentini, M., Filippini, M., Felder, M., Bonoldi, M.C., Moroder, E.: Therapie mit Cimetidin beim Ulcus duodeni. M.M.W. 120, 839–842 (1978)Google Scholar
  56. 55.
    Domschke, S., Domschke, W.: New histamine H2-receptor antagonists. Acta Hepatogastroenterol. (Stuttg.) 27, 163–168 (1980)Google Scholar
  57. 56.
    Domschke, W., Domschke, S., Lux, G., Belohlavek, S., Neidhardt, B., Demling, L.: Wirksame Cimetidin-Therapie beim Ulcus duodeni. Dtsch. Med. Wochenschr. 101, 1752–1755 (1976)PubMedCrossRefGoogle Scholar
  58. 57.
    Domschke, W., Lux, G., Domschke, S.: Furan H2-Antagonist inhibits pentagastrin stimulated gastrin secretion stronger than Cimetidine. Gastroenterol. 79, 1667–1671 (1980)Google Scholar
  59. 58.
    Domschke, W., Lux, G., Domschke, S.: Gastric inhibitory action of H2-antagonist ranitidine and cimetidine. Lancet 1979 I, 320Google Scholar
  60. 59.
    Dronfield, M.W., Batchelor, A.J., Larkworthy, W., Langman, M.J.S.: Controlled trial of maintenance cimetidine treatment in healed duodenal ulcers: Short and long-term effects. Gut 20, 526–530 (1979)PubMedCrossRefGoogle Scholar
  61. 60.
    Druart, F., Frocrain, C., Metois, P., et al.: Association of cimetidine and bone-marrow suppression in man. Dig. Dis. Sci. 24, 730–731 (1979)PubMedCrossRefGoogle Scholar
  62. 61.
    Dyck, W.P., Belsito, A., Fleshier, B., Liebermann, T.R., Dickinson, P.B., Wood, J.M.: Cimetidine and placebo in the treatment of benign gastric ulcer. A multicentre double blind study. Gastroenterol. 74, 410–415 (1978)Google Scholar
  63. 62.
    Dykes, P.W., Hoare, E.M., Hawkins, C.F., Kang, J.Y.: The treatment of upper gastrointestinal hemorrhage with Cimetidine. In: Cimetidine - The Westminster Symp. 1978. Wastell, C., Lance, P. (eds.), pp. 177–179. Edinburgh: Churchill Livingstone 1978Google Scholar
  64. 63.
    Editorial: Cimetidine and the acid aspiration syndrome. Lancet 1980 I, 465–466Google Scholar
  65. 64.
    Edmonds, M.E., Ashford, R.F.U., Brenner, M.K., Saunders, A.: Cimetidine: Does neurotoxicity occur? Report of three cases. J.R. Soc. Med. 72, 172 (1979)PubMedGoogle Scholar
  66. 65.
    Elder, J.B., Ganguli, P.C., Gillespie, I.E., Cimetidine and gastric cancer. Lancet 1979 I, 1005–1006Google Scholar
  67. 66.
    Ellis, D.J., Hamer, J.D., Baker, S.E.: Perforation of duodenal ulcer during treatment with cimetidine. Br. Med. J. 1977 II, 1583Google Scholar
  68. 67.
    Englert, E., Freston, J.W., Graham, D.Y., et al.: Cimetidine, antacid, and hospitalisation in the treatment of benign gastric ulcer. A multicentre double blind study. Gastroenterol. 74, 416–425 (1978)Google Scholar
  69. 68.
    Esposito, R.: Cimetidine and iron-deficiency anaemia. Lancet 1977 II, 1132Google Scholar
  70. 69.
    Eustace, I.E., FitzGerald, O., McMullin, J.P.: Role of Cimetidine in relapse-prevention of duodenal ulcers healed by Cimetidine. Ir. J. Med. Sci. 147, 272–275 (1978)PubMedCrossRefGoogle Scholar
  71. 70.
    Feldman, E.J. Isenberg, J.I.: Effects of metiamide on gastric acid hypersecretion, steatorrhea and bone marrow function in a patient with systemic mastocytosis. N. Engl. J. Med. 295, 1178–1179 (1976)PubMedCrossRefGoogle Scholar
  72. 71.
    Ferguson, R., Dronfield, M.W., Atkinson, M.: Cimetidine in treatment of reflux oesophagitis with peptic stricture. Br. Med. J. 1979 II, 472–474Google Scholar
  73. 72.
    Fiasse, R., Hanin, C., Lepot, A., Descamps, C., Dive, C.: A double-blind placebo-controlled study of Cimetidine in reflux oesophagitis. In: Cimetidin-Symp. Brüssel 1977, pp. 126–135. Amsterdam: Excepta Medica 1977Google Scholar
  74. 73.
    Fielding, L.P., Chalmers, D.M., Chanarin, I., Levi, A.J.: Inhibition of intrinsic factor secretion by cimetidine. Br. Med. J. 1978 I, 818–819Google Scholar
  75. 74.
    Figueroa, R.B., Espejo, H.R.: Cimetidine in active duodenal ulcer. Curr. Ther. res. 25, 16–24 (1979)Google Scholar
  76. 75.
    Flind, A.C.: Cimetidine and oral anticoagulants. Br. Med. J. 1978 II, 1367Google Scholar
  77. 76.
    Forrest, J.A.H., Shearman, D.J.C., Spence, R., Celestin, L.R.: Neutropenia associated with metiamide, Lancet 1975 I, 392–393Google Scholar
  78. 77.
    Frost, F., Rahbek, I., Rune, S.J.: Cimetidine in patients with gastric ulcer: A multicentre controlled trial. Br. Med. J. 1977 II, 795–799Google Scholar
  79. 78.
    Garcia, V.G., Chantres, D., Paredes, G., Rosso, L.: La cimetidina en el tratamiento de la ulcera peptica. Estudio doble ciego (abstract). VI. World Congr. Gastroenterol, Madrid, (1978) 19Google Scholar
  80. 79.
    Giacosa, A., Farris, A., Cheli, R.: Cimetidine and psoriasis. Lancet 1978 II, 1211Google Scholar
  81. 80.
    Gibson, R., Hirschowitz, B.I., Hutchison, G.: Actions of metiamide, an histamin H2- receptor antagonist, on gastric H+ and pepsin secretion. Gastroenterol. 67, 93–99 (1974)Google Scholar
  82. 81.
    Gill, M.J., Saunders, J.B.: Perforation of chronic peptic ulcers after cimetidine. Br. Med. J. 1977 II, 1149Google Scholar
  83. 82.
    Gillespie, G., Gray, G.R., Smith, I.S., Mackenzie, I.: Long term treatment in severe duodenal ulcer dyspesia (abstract). VI. World Congr. Gastroenterol, Madrid (1978) 140Google Scholar
  84. 83.
    Gray, G.R., McKenzie, I., Smith, I.S., Crean, G.P., Gillespie, G.: Oral Cimetidine in severe duodenal ulceration. Lancet 1977 I, 4–7Google Scholar
  85. 84.
    Griffiths, R., Lee, R.M., Taylor, T.C.: Kinetics of Cimetidine in man and experimental animal. In: Proc. 2nd international Symposium Histamine H2-Receptor Antagonists. Burland, W.L., Simkins, M.A. (eds.), pp. 38–51. Amsterdam: Excerpta Medica 1977Google Scholar
  86. 85.
    Grimson, T.A.: Cimetidine and mental confusion. Lancet 1977 I, 858Google Scholar
  87. 86.
    Gudmand-H0yer, E., Birger-Jensen, K., Krag, E., Rask-Madsen, J., Rahbek, I., Rune, S.J., Wulff: Prophylactic effect of Cimetidine in duodenal ulcer disease. Br. Med. J. 1978 I, 1095–1097Google Scholar
  88. 87.
    Güemes, F.: Short and long-term effects of trithiozine and cimetidine followed or not by maintenance treatment in duodenal ulcer (abstracts). XI. Int. Congress of Gastroenterol. Hamburg, 1980. Acta Hepatogastroenterol. (Stuttg.) 49 (1980)Google Scholar
  89. 88.
    Gyr, K., Kayasseh, L., Keller, U., Stalder, G.A.: Somatostatin und Cimetidin bei akuter Ulcusblutung. Eine randomisierte, kontrollierte Studie. Z. Gastroenterol. 18, 342–343 (1980)PubMedGoogle Scholar
  90. 89.
    Hall, W.H.: Brest changes in males on cimetidine. N. Engl. J. Med. 295, 841 (1976)PubMedGoogle Scholar
  91. 90.
    Halloran, L.G., Zfass, A.M., Gayle, W.E., Wheeler, C.B., Miller, J.D.: Prevention of acute gastrointestinal complications after severe head injury: A controlled trial of cimetidine prophylaxis. Am. J. Surg. 139, 44–48 (1980)PubMedCrossRefGoogle Scholar
  92. 91.
    Halter, F., Witzel, L.: Increased acid secretion after sustained metiamide medication in the rat. Gastroenterol. 72, 816 (1977)Google Scholar
  93. 92.
    Hansky, J., Korman, M.G.: Long-term Cimetidine in duodenal ulcer disease. Dig. Dis. Sci. 24, 465–467 (1979)PubMedCrossRefGoogle Scholar
  94. 93.
    GestrichenGoogle Scholar
  95. 94.
    Hentschel, E., Schütze, K., Havelec, L.: Die Behandlung des Ulcus duodeni und des präpylorischen Ulcus mit Cimetidin. Eine Doppelblindstudie. Wien. Klin. Wo- chenschr. 94, 53–57 (1979)Google Scholar
  96. 95.
    Hentschel, E., Schütze, K., Judmaier, G., Reichel, W., Kerstan, E., Poeschi, E., Rüdiger, E., Weiss, W.: The effect of Cimetidine treatment in the prevention of gastric ulcer relapse. In press.Google Scholar
  97. 96.
    Hetzel, D.J., Taggart, G.J., Hansky, J., Hecker, R., Shearman, J.C.: Cimetidine in the treatment of duodenal ulcer. Med. J. Aust. 1, 317–319 (1977)PubMedGoogle Scholar
  98. 97.
    Hetzel, D.J., Hansky, J., Shearman, D.J.C., et al.: Cimetidine treatment of duodenal ulceration. Short term clinical trial and maintenance study. Gastroenterol. 74, 389–392 (1978)Google Scholar
  99. 98.
    Hirschowitz, B.I.; Groarke, J.F.: Effect of cimetidine on gastric hypersecretion and diarrhea in systemic mastocytosis. Ann. Intern. Med. 90, 769–771 (1979)PubMedGoogle Scholar
  100. 99.
    Hoste, P., Ingels, J., Elewaut, A., Barbier, F.: Duodenal perforation after cimetidine. Lancet 1978 1, 666 Google Scholar
  101. 100.
    Idvall, J.: Cimetidine-associated thrombocytopenia. Lancet 1979 II, 159Google Scholar
  102. 101.
    Ippoliti, A.F., Sturdevant, R.A.L., Isenberg, J.I., et al.: Cimetidine versus intensive antacid therapy for duodenal ulcer. A multicentre trial. Gastroenterol. 74, 393–395 (1978)Google Scholar
  103. 102.
    Jeffreys, D.B., Vale, J.A.: Cimetidine and bradycardia. Lancet 1978 I, 828Google Scholar
  104. 103.
    Jensen, K.B., Mollmann, K.M., Rahbek, I., Madsen, J.R., Rune, S.J., Wulff, H.R.: Prophylactic effect of cimetidine in gastric ulcer patients. Scand. J. Gastroenterol. 14, 175–176 (1979)PubMedCrossRefGoogle Scholar
  105. 104.
    Johnson, Mcl. N., Black, A.E., Hughes, A.S.B., Clarke, S.W.: Leucopenia with Cimetidine. Lancet 1977 II, 1226Google Scholar
  106. 105.
    Kang, J.Y., et al.: The use of long-term Cimetidine in the prevention of gastric ulcer relapse: Double blind trial (abstract). Annual Sci. Meeting, Gastroenterol. Soc.Australia, A9. 1979Google Scholar
  107. 106.
    Keighley, B.D.: Perforation of peptic ulcer after withdrawal of cimetidine. Br. Med. J. 1977 II, 1538Google Scholar
  108. 107.
    Keighley, M.R.B., Muscroft, T.J., Youngs, D., Burdon, D.W.: Malignant potential of hypochlorhydria. Drug symposium on Cimetidine. XI. Intern. Congr. Gastroenterol. Hamburg 1980Google Scholar
  109. 108.
    Klotz, U., Anttila, V.J., Reimann, I.: Cimetidine/Diazepam interaction. Lancet 1979 II, 699Google Scholar
  110. 109.
    Konturek, S.J., Obtulowicz, W., Kwiecien, N., et al.: Effect of Ranitidine, a new H2-antagonist on gastric and pancreatic secretion in duodenal patients. Dig. Dis. Sci. 25, 737–743 (1980)PubMedCrossRefGoogle Scholar
  111. 110.
    Konturek, S.J., Oleksy, J., Obtulowicz, W., Sito, E.: Inhibition of cholinergic, meal-, pentagastrin- and histamin-induced gastric secretion by ranitidine. In: Ranitidine. Classen, M., Schöffling, K., Konturek, S.J. (eds.). (to be published)Google Scholar
  112. 111.
    Korman, M.G., Hetzel, D.J., Hansky, J., Shearman, D.J.C., Don, G.: Relapse rate of duodenal ulcer after cessation of long-term Cimetidine treatment. Dig. Dis. Sci. 25, 88–91 (1980)PubMedCrossRefGoogle Scholar
  113. 112.
    Kowalewski, K., Kolodej, A.: Effect of metiamide, a histamine antagonist of H2-receptors, on acid secretion of isolated canine stomach perfused with homologous blood. Pharmacology 11, 207–212 (1974)PubMedCrossRefGoogle Scholar
  114. 113.
    Lambert, R., Bader, J.-P., Bernier, J.J., et al.: Traitement de l’ulcère gastrique et duodenal par la cimétine. Gastroenterol. Clin. Biol. 1, 855–860 (1977)PubMedGoogle Scholar
  115. 114.
    Langman, M.J.S., Henry, D.A., Burnham, A., Ogilvie, M.W.: A comparison of ranitidine andcimetidine in duodenal ulcer. IV. Europ. Congress of Gastroint. Endoscopy. Drug symposium on ranitidineGoogle Scholar
  116. 115.
    Lepsien, G., Sonnenberg, A., Berges, W., Wienbeck, J., Siewert, J.R., Blum, A.L.: Die Behandlung der Refluxösophagitis mit Cimetidin. Dtsch. Med. Wochenschr. 104, 901–906 (1979)PubMedCrossRefGoogle Scholar
  117. 116.
    Levi, R., Trzeciakowski, J.P.: Cimetidine and sinus node function. N. Engl. J. Med. 302, 235 (1980)PubMedGoogle Scholar
  118. 117.
    Lewin, M.J.M, Sourmarmon, A., Bonfils, S.: Receptors for gastrin and histamine in gastric mucosa. Prog. Gastroenterol. 111, 203–240 (1977)Google Scholar
  119. 118.
    Lombardo, L., Pera, A., Crivelli, O., et al.: Antral G- and D-cells after Cimetidine in duodenal ulcer. It. J. Gastroenterol. 11, 138 (1979)Google Scholar
  120. 119.
    Londong, W., Londong V., Prechtl, R., Schwanner, A.: Untersuchungen zur Effektivität von Cimetidin, Pirenzepin und synthetischem Sekretin auf die stimulierte Magensäuresekretion. Z. Gastroenterol. 18, 306–313 (1980)PubMedGoogle Scholar
  121. 120.
    Longstreth, G.F., Go, V.L.W., Malagelada, J.-R.: Cimetidine suppression of nocturnal gastric secretion in active duodenal ulcer. N. Engl. J. Med. 294, 801–804 (1976)PubMedCrossRefGoogle Scholar
  122. 121.
    Lopez-Luque, A., Rodriguez-Cuartero, A., Perez-Galvez, N., Pomares-Mora, J., Pena-Yanez, A.: Cimetidine and bone-marrow toxicity. Lancet 1978 I, 444Google Scholar
  123. 122.
    Lorenz, W., Doenicke, A., Dittmann, I., Hug, P., Schwarz, B.: Anaphylaktoide Reaktionen nach Applikation von Blutersatzmitteln beim Menschen. Anaesthesist 26, 644–648 (1977)PubMedGoogle Scholar
  124. 123.
    Lyons, F., Cook, J., Shuster, S.: Inhibition of sebum excretion by an H2-blocker. Lancet 1979 I, 1376Google Scholar
  125. 124.
    MacDougall, B.R.D., Williams, R.: Role of Cimetidine in the management of bleeding in liver disease. In: Cimetidine—The Westminster Symp. Wastell, C., Lance, P. (eds.), pp. 180–188. Edinburgh: Churchill Livingstone 1978Google Scholar
  126. 125.
    Machell, R.J., Ciclitira, P.J., Farthing, M.J.G., Dick, A.P., Hunter, J.O.: Maintenance cimetidin in the prevention of gastric ulcer relapse. Lancet 1978 I, 663Google Scholar
  127. 126.
    Martin, D., Hollanders, D., May, S., Ravenscroft, M., Tweedle, D., Miller, J.P.: Difference in relapse rates of duodenal ulcer after healing withCimetidine or tripotassium dicitrato bismuthate. Lancet 1981 I, 7–10Google Scholar
  128. 127.
    Massarat, S., Hausmann, L., Heuser, E., Klingemann, H.G., Schubotz, R.: Langzeittherapie beim Ulcus duodeni. Z. Gastroenterol. 17, 633 (1979)Google Scholar
  129. 128.
    McAdam, W.A.F., Pacsoo, C., Morgan, A.G.: A comparison between Caved-S and Cimetidine in gastric ulcer treatment and subsequent maintenance therapy. XI. Intern. Congress of Gastroent. Hamburg 1980 (abstracts). Acta Hepato Gastroenterol (Stuttg.) 205Google Scholar
  130. 129.
    McCarthy, D.M., Peikin, S.R., Lopatin, R.N., Crossley, R.J., Harpel, H.S.: H2-receptor antagonists in gastric hypersecretory states. In: Cimetidin Symposium, Goettingen 1977. Creutzfeldt, W. (eds.), pp. 153 - 168. Amsterdam, New York: Excerpta Medica 1978Google Scholar
  131. 130.
    McDaniel, J.L., Stein, J.J.: Thrombocytopenia with Cimetidine therapy. N. Engl. J. Med. 300, 864 (1979)PubMedGoogle Scholar
  132. 131.
    McIntosh, F.C.: Histamine as normal stimulant of gastric secretion. Q. J. Exp. Physiol. 28, 87 (1938)Google Scholar
  133. 132.
    Mekel, R.C.P.M.: Two-year maintenance treatment with Cimetidine for duodenal ulcers. S. Afr. Med. J. 57 293 (1980)Google Scholar
  134. 133.
    Menzies-Gow, N.: Cimetidine and mental confusion. Lancet1977 II, 928Google Scholar
  135. 134.
    Meredith, T.J., Volans, G.N.: Management of Cimetidine overdose. Lancet 1979 II, 1367Google Scholar
  136. 135.
    Meshkinpour, H., Molineri, M.D., Gardner, L., et al.: Cimetidine in the treatment of acute alcoholic pancreatitis. A randomized, double blind study. Gastroenterology 77, 687–690 (1979)PubMedGoogle Scholar
  137. 136.
    Mills, J.G., Hunt, R.H., Burland, W.L., Milton-Thompson, G.J.: Impromidine as a gastric secretagogue in comparative studies with a new H2-receptor antagonist (SKF 92994) XI Int. Congress of Gastroent. Hamburg 1980 (abstracts). Acta Hepatogastroenterol. 261Google Scholar
  138. 137.
    Morgan, A.G., McAdam, W.A.F., Pacsoo, C., Walker, B.E., Simmons, A.V.: Cimetidine: An advance in gastric ulcer treatment? Br. Med. J. 1978 II, 1323–1326Google Scholar
  139. 138.
    Moshal, M.G., Spitaels, J.M., Bhoola, R.: Treatment of duodenal ulcers with Cimetidine. S. Afr. Med. J. 52, 760–763 (1977)PubMedGoogle Scholar
  140. 139.
    Moshal, M.G., Spitaels, J.M., Khan, F.: A double-blind endoscopically controlled trial of ranitidine in a high incidence area. IV Europ. Congress of Gastroint. Endoscopy, Hamburg 1980, Drug Symp. on ranitidine.Google Scholar
  141. 140.
    Murakami, T.: Early gastric cancer. Baltimore: University Park Press 1972Google Scholar
  142. 141.
    Navert, H., Larose, L., Beaudry, R., Haddad, H., Lufti, G., Lacruz, M., Apollon, G.: Cimetidine is effective in the treatment of gastric ulcer. Gastroenterology 74, 1072 (1978)Google Scholar
  143. 142.
    Nelson, P.G.: Cimetidine and mental confusion. Lancet 7977/7, 928Google Scholar
  144. 143.
    Nistico, G., Rotiroti, D., De Sarro, A., Naccari, F.: Mechanism of cimetidine-induced fever. Lancet 1978 II, 265–266Google Scholar
  145. 144.
    GestrichenGoogle Scholar
  146. 145.
    Ottenjann, R., Kunert, H.: Praktische Erfolge in der stationären Therapie des peptischen Ulkus mit H2-Rezeptor-Blockern. In: Peptische Läsion im Lichte von Aggression und Protektion. Demling, L., Rösch, W. (Hrsg.), S. 88–94. Baden-Baden: Witzstrock 1978Google Scholar
  147. 146.
    Peden, N.R., Saunders, J.H.B., Wormsley, K.G.: Inhibition of pentagastrin-stimulated and nocturnal gastric secretion by ranitidine. Lancet 1979 I, 690–692Google Scholar
  148. 147.
    Peter, P., Gonvers, J.J., Pelloni, S., et al.: Cimetidin in der Behandlung des Ulcus duodeni. Dtsch. med. Wschr. 103, 1163–1166 (1978)PubMedCrossRefGoogle Scholar
  149. 148.
    Petrokubi, R.J., Jeffries, G.H.: Cimetidine versus antacids in scleroderma with reflux oesophagitis. Gastroenterology 74, 1077 (1978)Google Scholar
  150. 149.
    Phanuphak, P., Schocket, A., Kohler, P.F.: Treatment of chronic idiopathik urticaria with combined HI and H2 blockers. Clin. Allergy 8, 429–433 (1978)PubMedCrossRefGoogle Scholar
  151. 150.
    Popielski, I.: Beta-Imidazolyläthylamin und die Organextrakte. 1. Beta-Imidazolylät- hylamin als mächtiger Erreger der Magendrüsen. Pfluegers Arch. Ges. Physiol. 178, 214–236 (1920)CrossRefGoogle Scholar
  152. 151.
    Pounder, R.E., Williams, J.G., Hunt, R.H., Vincent, S.H., Milton-Thompson, G.J. Misiewicz, J.J.: The effects of oral Cimetidine on food-stimulated gastric secretion and 24-hour intragastric acidity. In: Proc. 2nd International Symposium on Histamine H2- Receptor Antagonists. Burland, W.L., Simkins, M.A. (eds.), pp. 189 - 204. Amsterdam: Excerpta Medica 1977Google Scholar
  153. 152.
    Powell-Jackson, P., Barkley, H., Northfield, T.C.: Effect of cimetidine in symptomatic gastroesophageal reflux. Lancet 1978 II, 1068–1069Google Scholar
  154. 153.
    Premont, M., Poilleux, J., Dazza, F.: Perforations d’ulcères gastro-duodénaux et Cimetidine. Chirurgie 104, 787–791 (1978)PubMedGoogle Scholar
  155. 154.
    Priebe, H.J., Skilimann, J.J., Bushneil, L.S., Long, P.C., Silen, W.: Antacids versus cimetidine in preventing acute gastrointestinal bleeding. N. Engl. J. Med. 1980 I, 426–430Google Scholar
  156. 155.
    Rai, G.S., Webster, S.G.P.: Cimetidine and psoriasis. Lancet 1979 I, 50Google Scholar
  157. 156.
    Ramboer, C.: Drug fever with cimetidine. Lancet 1978 I, 330–331Google Scholar
  158. 157.
    Reding, P., Devroede, C., Barbier, P.: Bradycardia after cimetidine. Lancet 1977 II, 1227Google Scholar
  159. 158.
    Reed, P.I., Cassel, P.G., Walters, C.L.: Gastric cancer in patients who have taken cimetidine. Lancet 1979 I, 1235Google Scholar
  160. 159.
    Richardson, T.C.: Effect of H2-receptor antagonists on gastric acid secretion and serum gastrin concentration. A review. Gastroenterology 74, 366–370 (1978)PubMedGoogle Scholar
  161. 160.
    Robertson, A.J., Peden, N.R., Saunders, J.H.B, et al.: Cimetidine and the immuneresponse. Lancet 1979 11, 420–421Google Scholar
  162. 161.
    Robinson, T.J., Mulligan, T.O.: Cimetidine and mental confusion. Lancet 1977 II, 719Google Scholar
  163. 162.
    Rogers, H.J., House, F.R., Morrison, P.J., Bradbook, I.D.: Interaction of cimetidinewith tetracycline absorption. Lancet 1980 II, 694Google Scholar
  164. 163.
    Rohde, H., Lorenz, W., Fischer, M.: Eine randomisierte klinische Studie zur Streßul- kusprophylaxe mit Cimetidin beim schweren Polytrauma. Z. Gastroenterol. 18, 328–329 (1980)PubMedGoogle Scholar
  165. 164.
    Rowley-Jones, D.: Cimetidine and serum-prolactin. Lancet 1978 II, 635Google Scholar
  166. 165.
    Salera, M., Taroni, F., Miglioli, M., Santini, D., Milazzo, G., Gizzi, G.; Barbara, L.: Prophylaxis of duodenal ulcer recurrance: Effects and follow-up of long-term treatment with cimetidine. It. J. Gastroenterol. 11, 138 (1979)Google Scholar
  167. 166.
    Salom, I., Doscherholmen, A., Silvis, S.: Cimetidine decreases absorption of food- bound vitamin B12. Gastroenterology 78, 1250 (1980)Google Scholar
  168. 167.
    Schentag, J.J., Calleri, G., Rose, Q.J., Cerra, F.B., DeGlopper, E., Bernhard, H.: Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusion. Lancet 1979 I, 177–181Google Scholar
  169. 168.
    Schöön, I.-M., Olbe, L.: Effect of Cimetidine on cholinergic reflex stimulation of gastric acid secretion in duodenal ulcer patients. In: Cimetidine. Burland, W.L., Simkins, M.A. (eds.), pp. 207–213. Amsterdam, Excerpta Medica 1977Google Scholar
  170. 169.
    GestrichenGoogle Scholar
  171. 170.
    Semb, L.S., Berstad, A., Myren, J., Foss, J.C., Carlsen, E., Kruse-Jensen, A.: A double-blind multicentre comparative study of Cimetidine and placebo in short-term treatment of active duodenal ulceration. In: Proc. 2nd International Symposium Histamine H2-Receptor Antagonists. Burland, W.L., Simkins, M.A. (eds.), pp. 248–253. Amsterdam: Excerpta Medica 1977Google Scholar
  172. 171.
    Serlin, M.J., Sibeon, R.G., Mossman, S., et al.: Cimetidine: Interaction with oral anticoagulants in man. Lancet 1979 II, 317–319Google Scholar
  173. 172.
    Sharpe, P.C. Hawkins, B.W.: Efficacy and safety of Cimetidine. Long-term treatment with Cimetidine. In: Proc. 2nd International Symposium on Histamine H2-Receptor Antagonists. Burland, W.L., Simkins, M.A. (eds)., p. 358–366. Amsterdam: Excerpta Medica 1977Google Scholar
  174. 173.
    Silver, B.A., Bell, W.R.: Cimetidine potentiation of the hypoprothrombinemic effect of warfarin. Ann. Intern. Med. 90, 348 (1979)PubMedGoogle Scholar
  175. 174.
    Simon, B., Kather, H.: Hemmung der pentagastrin-stimulierten Magensekretion durch Ranitidin. Dtsch. Med. Wochenschr. 104, 1676–1678 (1979)PubMedCrossRefGoogle Scholar
  176. 175.
    Soll, A.H.: Secretagogue interactions on the canine isolated parietal cell. In: Gastrins and the vagus. Rehfeld, J.F., Amdrup, E. (eds.). London: Academic Press 1979Google Scholar
  177. 176.
    Soll, A.H., Grossmann, M.I.: Regulation of parietal cell function. In: Advances in ulcer disease. Holtermüller, K.-H., Malagelada, J.-R. (eds.) pp. 164–175. Amsterdam: Excerpta Medica 1980Google Scholar
  178. 177.
    Sonnenberg, A., Kien, K.B., Pelloni, S., Wienbeck, M., Strohmeyer, G., Blum, A.L.: Rezidivprophylaxe des Ulcus duodeni mit Cimetidin. Dtsch. Med. Wochenschr. 104, 725–730 (1979)PubMedCrossRefGoogle Scholar
  179. 178.
    Spence, R.W., Celestin, L.R., McCormick, D.A.: Effect on gastric acid output of prolonged treatment with cimetidine in duodenal ulcer patients. Gut 77, 831 (1976)Google Scholar
  180. 179.
    Spence, R.W., Celestin, L.R., McCormick, D.A.: Effect of one year’s treatment with cimetidine on parietal cell mass in duodenal ulcer patients. Gut 18, A420–A421 (1977)Google Scholar
  181. 180.
    Spence, R.W., McCormick, D.A., Oliver, J.M., Celestin, L.R.: The effect on serum gastrin of withdrawal of Cimetidine after one year’s treatment. In: Cimetidine. The Westminster Hospital Symposium 1978. Wastell, C., Lance, P. (eds.), pp. 153–169. Edinburgh: Churchill Livingstone 1978Google Scholar
  182. 181.
    Soll, A.H.: Effects of H2-antagonists on histamine action and interaction with gastrin in isolated parietal cells. Gastroenterology 74, 355 (1978)PubMedGoogle Scholar
  183. 182.
    Spiegel, A.M., Lopatin, R., Peikin, S., McCarthy, D.: Serum-prolactin in patients receiving chronic oral cimetidine. Lancet 1978 I, 881Google Scholar
  184. 183.
    Steinberg, W.M., King, C.E., Toskes, P.P.: Malabsorption of proteinbound cobalamin but not unbound cobalamin during Cimetidine administration. Dig. Dis. Sci. 25, 188–192 (1980)PubMedCrossRefGoogle Scholar
  185. 184.
    Terés, J., Bordas, J.M., Rimola, A., Bru, C., Rodes, J.: Cimetidine in acute gastric mucosal bleeding. Dig. Dis. Sci. 25, 92–96 (1980)PubMedCrossRefGoogle Scholar
  186. 185.
    Turkie, P.V.: Perforation of peptic ulcer after withdrawal of cimetidine. Br. Med. J. 1977 II, 1022Google Scholar
  187. 186.
    Ubilluz, R.: Cimetidine in the treatment of active duodenal ulceration: A double-blind study. Curr. Ther. Res. 25, 243–250 (1979)Google Scholar
  188. 187.
    Ufberg, M.H., Brooks, C.M., Bosanac, C.R., Kintzel, J.E.: Transient neutropenia in a patient receiving cimetidine. Gastroenterology 73, 635–638 (1977)PubMedGoogle Scholar
  189. 188.
    Valcavi, R., Bedogni, G., Dall’Asta, A., et al.: Single oral dose of cimetidine and prolactin. Lancet 1978 II, 528Google Scholar
  190. 189.
    Van Rijthoven, A.W.A.M.: Cimetidine intoxication. Lancet 1979 II, 370Google Scholar
  191. 190.
    Van Thiel, D.H., Gavaler, J.S., Smith, W.I., Gwendolyn, P.: Hypothalamic-pituitary- gonadal dysfunction in men using Cimetidine. N. Engl. J. Med. 300, 1012–1015 (1979)PubMedCrossRefGoogle Scholar
  192. 191.
    Villalobos, M.M., Avella, J.: Ulcera gastrica: Estudio doble ciego comparativa con cumetidina-placeebo (abstract). VI. World Congress of Gastroenterol. Madrid (1978) 221Google Scholar
  193. 192.
    Villeneuve, J.P., Warner, H.A.: Cimetidine hepatitis. Gastroenterology 77, 143–144 (1979)PubMedGoogle Scholar
  194. 193.
    Wallace, W.A., Orr, C.M.E., Beam, A.R.: Perforation of chronic peptic ulcers after cimetidine. Br. Med. J 1977 II, 865–866Google Scholar
  195. 194.
    Wallach, D., Decazes, J.M., Cottenot, F.: Psoriasis sévère amélioré de façon spectaculaire au cours d’un traitement par cimétidine. Nouv. Presse Med. 8, 2981 (1979)PubMedGoogle Scholar
  196. 195.
    Walt, R.P., Male, P.J., Rawlings, J., Torrie, P., Hunt, R.H., Misiewicz, J.J., Milton- Thompson, G.J.: 24-hour intragastric acidity in duodenal ulcer patients on a new twice-daily H2-receptor antagonist. Gut 20, A904–905 (1979)Google Scholar
  197. 196.
    Wesdorp, E., Bartelsman, J., Pape, K., Dekker, W., Tytgat, G.N.: Oral Cimetidine in reflux oesophagitis. Gastroenterology 74, 821–824 (1978)PubMedGoogle Scholar
  198. 197.
    White, M.C., Gore, M., Jewell, D.P.: Endocrine function after cimetidine. N. Engl. J. Med. 301, 502 (1979)PubMedCrossRefGoogle Scholar
  199. 198.
    Winters, S.J., Banks, J.L., Loriaux, L.: Cimetidine is an antiandrogen in rats. Gastroenterology 76, 504–508Google Scholar
  200. 199.
    Wormsley, K.G., Saunders, J.H.B.: Maintenance treatment of duodenal ulceration with metiamide. In: Proc. 2nd International Symposium Histamine H2-Receptor Antagonists. Burland, W.L., Simkins, M.A. (eds.), pp. 275–276. Amsterdam: Excerpta Medica 1977Google Scholar
  201. 200.
    Wulff, H.R.: Cimetidine in the treatment of gastric ulcer. In: International Symposium on Histamine H2-Receptor Antagonists. Creutzfeldt, W. (ed.). Amsterdam: Excerpta Medica 1978Google Scholar
  202. 201.
    Züchner, H.: Cholestatische Hepatose unter Cimetidin. Dtsch. Med. Wochenschr. 102, 1788 (1977)PubMedGoogle Scholar
  203. 202.
    Zumtobel, V., Teichmann, R.K., Inthorn, D.: Prophylaxe und Therapie gastroduode- naler Streßblutungen mit Cimetidin. Z. Gastroenterol. 18, 330–333 (1980)PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1982

Authors and Affiliations

  • E. Hentschel

There are no affiliations available

Personalised recommendations